Deutsche Bank
OCAT

Deutsche Bank’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Deutsche Bank’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,546
Closed -$95K – 5553
2015
Q4 		$95K Sell
11,546
-12
-0.1% -$80 ﹤0.01% 4087
2015
Q3 		$48K Buy
11,558
+2,988
+35% +$13K ﹤0.01% 4477
2015
Q2 		$45K Buy
+8,570
New +$54.9K ﹤0.01% 4641

Deutsche Bank's OCAT Position: Q1 2016 in Review

Deutsche Bank sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 11,546 shares — an estimated $95K sold.

Deutsche Bank first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $95K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Deutsche Bank reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Deutsche Bank sold 11,546 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $95K.
  • Deutsche Bank first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Deutsche Bank's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $95K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Deutsche Bank's 13F filing for Q1 2016, filed 16 May 2016.